Recombinant multi-species USP9X protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine USP9X protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the peptidase C19 family and encodes a protein that is similar to ubiquitin-specific proteases. Though this gene is located on the X chromosome, it escapes X-inactivation. Mutations in this gene have been associated with Turner syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 5730589N07Rik,DFFRX,Deubiquitinating enzyme FAF-X,Dffrx,FAF,FAF-X,FAM,Fafl,Fat facets in mammals (hFAM),Fat facets protein-related,MRX99,MRXS99F,RGD1560056,USP9X,Ubiquitin carboxyl-terminal hydrolase 9X,Ubiquitin thioesterase FAF-X,Ubiquitin-specific protease 9,Ubiquitin-specific-processing protease FAF-X,Usp9x,X chromosome,X-linked,XLID99,hFAM

Target products collectionGo to USP9X products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12612-Ag-1/ GM-Tg-hg-IP12612-Ag-2 Human USP9X protein Human
GM-Tg-rg-IP12612-Ag-1/ GM-Tg-rg-IP12612-Ag-2 Rat USP9X protein Rat
GM-Tg-mg-IP12612-Ag-1/ GM-Tg-mg-IP12612-Ag-2 Mouse USP9X protein Mouse
GM-Tg-cynog-IP12612-Ag-1/ GM-Tg-cynog-IP12612-Ag-2 Cynomolgus/Rhesus macaque USP9X protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12612-Ag-1/ GM-Tg-felg-IP12612-Ag-2 Feline USP9X protein Feline
GM-Tg-cang-IP12612-Ag-1/ GM-Tg-cang-IP12612-Ag-2 Canine USP9X protein Canine
GM-Tg-bovg-IP12612-Ag-1/ GM-Tg-bovg-IP12612-Ag-2 Bovine USP9X protein Bovine
GM-Tg-equg-IP12612-Ag-1/ GM-Tg-equg-IP12612-Ag-2 Equine USP9X protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12612-Ag-1/ GM-Tg-hg-IP12612-Ag-2; GM-Tg-rg-IP12612-Ag-1/ GM-Tg-rg-IP12612-Ag-2;
GM-Tg-mg-IP12612-Ag-1/ GM-Tg-mg-IP12612-Ag-2; GM-Tg-cynog-IP12612-Ag-1/ GM-Tg-cynog-IP12612-Ag-2;
GM-Tg-felg-IP12612-Ag-1/ GM-Tg-felg-IP12612-Ag-2; GM-Tg-cang-IP12612-Ag-1/ GM-Tg-cang-IP12612-Ag-2;
GM-Tg-bovg-IP12612-Ag-1/ GM-Tg-bovg-IP12612-Ag-2; GM-Tg-equg-IP12612-Ag-1/ GM-Tg-equg-IP12612-Ag-2
Products Name USP9X protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name USP9X
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine USP9X protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.